Patent intelligence · US
US 11357727
Manufacturing of bupivacaine multivesicular liposomes
Manufacturing of bupivacaine multivesicular liposomes
Patent details — US 11357727
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 14, 2022
- Expiration
- Jun 9, 2042
- Applicant
- Pacira Pharmaceuticals, Inc.
- Claims
- 32
- CPC classes
- A61K, A61K31/445, A61K47/183, A61K47/26
Quick answer
US 11357727 (Manufacturing of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Jun 14, 2022. Expires Jun 9, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 32
- CPC classes
- A61K, A61K31/445, A61K47/183, A61K47/26, A61K9/0019, A61K9/0085
More from Pacira Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12370142
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12364764
Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same
granted -
US 12318483
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12296047
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12285435
Multivesicular liposome formulations of dexamethasone
granted -
US 12285419
Bupivacaine multivesicular liposome formulations and uses thereof
granted -
US 12280149
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12251472
Manufacturing of bupivacaine multivesicular liposomes
granted
Frequently asked questions
What is US patent 11357727?
US 11357727 (Manufacturing of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Jun 14, 2022. Expires Jun 9, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11357727?
Pacira Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 11357727 expire?
Our index shows an expiration date of Jun 9, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.